4DMedical Shareholders Defeat Proposed Executive Pay Packages
Investors at the annual meeting rejected remuneration plans totalling millions of dollars for top leadership.
Updated on Oct. 28, 2026 in Public Companies
Live Poll
Should shareholders consistently vote against high multi-million dollar executive pay packages?
Shareholders at 4DMedical have voted down all executive pay resolutions at the company's annual meeting. The move signals a major standoff between investors and the leadership of the $2.2 billion firm regarding proposed remuneration.
Why it matters
The rejection of these pay packages highlights growing shareholder scrutiny over executive compensation in the Australian corporate sector. Leadership has criticised the proxy advice that preceded this decisive vote as being rushed and overly generic.
Shareholders rejected a $10 million pay package for CEO Andreas Fouras and a $22 million proposal for CFO Julian Sutton. The company currently holds a market capitalisation of $2.2 billion.
The players
4DMedical
This Australian-based medical technology company develops respiratory imaging solutions and is listed on the stock exchange.
Andreas Fouras
He serves as the chief executive officer of 4DMedical and was subject to a proposed $10 million compensation package.
Julian Sutton
He is the chief financial officer of 4DMedical and was listed for a $22 million compensation package that shareholders rejected.
The details
Investors cast a 71 per cent vote against the adoption of the remuneration report during the meeting. Chief executive Andreas Fouras subsequently labelled the proxy advice that informed these decisions as rushed and generic in its assessment.
Timeline
4DMedical held its annual shareholder meeting on 21 October 2026.
Market Landscape
This event follows the standard governance mechanisms of the Australian Corporations Act's two-strikes rule on remuneration reports. It reflects a growing trend of investor activism where shareholders challenge high-value compensation structures to ensure alignment with performance.
This vote creates immediate uncertainty regarding the leadership structure and compensation costs at the firm. Retail investors should monitor future regulatory filings to see if the company proposes adjusted remuneration packages or faces further board-level challenges.
The takeaway
Shareholder activism remains a powerful tool for investors to check executive compensation plans that appear disconnected from firm performance. Investors should consistently review proxy statements and voting recommendations to understand how these disputes impact company stability.
Further reading
For more context on corporate governance and investor relations, visit the Public Companies section.
Source note: This article includes information reported by Australian Financial Review.
Live Poll
Should shareholders consistently vote against high multi-million dollar executive pay packages?
